Find disease awareness content and relevant supporting materials
Effectiveness of non-pharmacological nursing interventions to improve the quality of life of patients with idiopathic pulmonary fibrosis: A systematic review.
Aim: To evaluate whether non-pharmacological nursing interventions improve the quality of life, including both physical and psychosocial states, for patients with idiopathic pulmonary fibrosis, compared to patients receiving the usual care visit or not receiving routine nursing.
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
As idiopathic pulmonary fibrosis emerges as an important public health problem, there is a need to coordinate data on incidence and mortality globally. This study aims to systematically assess all available studies to investigate...
Health-related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry.
Background and objective: Studies analysing the effect of worsening pulmonary physiological impairment in idiopathic pulmonary fibrosis (IPF) with respect to quality of life have been limited to single centres or highly selected trial populations.
Under-recognised co-morbidities in idiopathic pulmonary fibrosis: A review.
Co?morbidities in idiopathic pulmonary fibrosis are common. These co?morbidities include obstructive sleep apnoea, gastro?oesophageal reflux disease, pulmonary hypertension and depression. The presence of co?morbidities...
Idiopathic pulmonary fibrosis: the radiologist's role in making the diagnosis.
Radiologists have a critical role in the evaluation and diagnosis of suspected idiopathic pulmonary fibrosis (IPF). Accurate pattern identification on imaging is key in the multidisciplinary diagnostic process and frequently obviates...
Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis.
Idiopathic pulmonary fibrosis is characterised by abnormal reepithelialisation and remodelling consequent to persistent stimuli or injury. The involvement of oxidative stress in alveolar injury, inflammation and fibrosis development...
Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscape.
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive-fibrosing interstitial lung disease of unknown origin that affects 3 million people worldwide and imparts substantial burdens to patients, their families, and the healthcare system.
Current approaches to the management of idiopathic pulmonary fibrosis.
Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal lung disease associated with dyspnoea, cough and impaired quality of life. Currently, the aims of patient care are to improve outcomes for patients by...